Revolution Medicines, Inc.(RVMD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RVMD Revolution Medicines, Inc.

盘前交易 12-19 09:06:02 EST

42.97

-2.19

-4.85%

盘前42.71

-0.26-0.61%

07:37 EST

最高45.77	最低42.71	成交量140.85万
今开45.27	昨收45.16	日振幅6.78%
总市值78.21亿	流通市值71.76亿	总股本1.82亿
成交额6,178万	换手率0.84%	流通股本1.67亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RVMD","market":"US","secType":"STK","nameCN":"Revolution Medicines, Inc.","latestPrice":42.97,"timestamp":1734555600000,"preClose":45.16,"halted":0,"volume":1408503,"hourTrading":{"tag":"盘前","latestPrice":42.71,"preClose":42.97,"latestTime":"07:37 EST","volume":21,"amount":903.4899300000001,"timestamp":1734611871388},"delay":0,"floatShares":167000000,"shares":182000000,"eps":-3.556464,"marketStatus":"盘前交易","marketStatusCode":1,"change":-2.19,"latestTime":"12-19 09:06:02 EST","open":45.27,"high":45.77,"low":42.71,"amount":61777448.64108,"amplitude":0.067759,"askPrice":45,"askSize":17,"bidPrice":42.61,"bidSize":20,"shortable":3,"etf":0,"ttmEps":-3.556464,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734618600000},"adr":0,"listingDate":1581570000000,"adjPreClose":42.97,"preHourTrading":{"tag":"盘前","latestPrice":42.71,"preClose":42.97,"latestTime":"07:37 EST","volume":21,"amount":903.4899300000001,"timestamp":1734611871388},"postHourTrading":{"tag":"盘后","latestPrice":40.83,"preClose":42.97,"latestTime":"19:55 EST","volume":42459,"amount":1821503.48,"timestamp":1734569713650},"volumeRatio":1.0252641203137622,"impliedVol":0.4661,"impliedVolPercentile":0.0677},"requestUrl":"/m/hq/s/RVMD/tweets","defaultTab":"tweets","newsList":[{"id":"2492151378","title":"Revolution Medicines, Inc.盘中异动 临近收盘急速下跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492151378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492151378?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:41","pubTimestamp":1734554512,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时41分，Revolution Medicines, Inc.股票出现异动，股价大幅跳水5.09%。Revolution Medicines, Inc.股票所在的生物技术行业中，整体跌幅为2.94%。Revolution Medicines, Inc.公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219044152984cb8e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219044152984cb8e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","BK4139"],"gpt_icon":0},{"id":"2492998581","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)股价重挫34.62% 市值跌1.09亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492998581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492998581?lang=zh_cn&edition=full","pubTime":"2024-12-18 01:06","pubTimestamp":1734455161,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日01时06分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价急速跳水34.62%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体涨幅为0.75%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218010601a1f64f38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218010601a1f64f38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMDW","BK4139","RVMD"],"gpt_icon":0},{"id":"2491697689","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 早盘股价大跌16.96%报0.260美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491697689","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491697689?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:32","pubTimestamp":1734359539,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时32分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价急速跳水16.96%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体跌幅为0.05%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223219a1f34306&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223219a1f34306&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RVMD","RVMDW"],"gpt_icon":0},{"id":"2490401207","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 股价大涨11.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490401207","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490401207?lang=zh_cn&edition=full","pubTime":"2024-12-10 23:37","pubTimestamp":1733845069,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日23时37分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现波动，股价急速上涨11.00%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体跌幅为1.22%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210233750ab6d1505&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210233750ab6d1505&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMDW","RVMD","BK4139"],"gpt_icon":0},{"id":"2490391771","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 大幅拉升11.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490391771","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490391771?lang=zh_cn&edition=full","pubTime":"2024-12-09 23:00","pubTimestamp":1733756408,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日23时00分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价大幅上涨11.39%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体涨幅为0.81%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209230008ab6a19f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209230008ab6a19f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMDW","BK4139","RVMD"],"gpt_icon":0},{"id":"2489266535","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 急速拉升7.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489266535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489266535?lang=zh_cn&edition=full","pubTime":"2024-12-07 04:35","pubTimestamp":1733517355,"startTime":"0","endTime":"0","summary":"北京时间2024年12月07日04时35分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价快速拉升7.19%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体涨幅为0.20%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241207043556971c3321&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241207043556971c3321&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMDW","RVMD","BK4139"],"gpt_icon":0},{"id":"2489363474","title":"美国研究综述-Doordash、Sagimet Biosciences、Ulta Beauty","url":"https://stock-news.laohu8.com/highlight/detail?id=2489363474","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489363474?lang=zh_cn&edition=full","pubTime":"2024-12-06 15:14","pubTimestamp":1733469271,"startTime":"0","endTime":"0","summary":"美国研究综述-Doordash、Sagimet Biosciences、Ulta Beauty路透社12月6日 - 华尔街证券分析师周五调整了对 Doordash、Sagimet Biosciences 和 Ulta Beauty 等几家美国上市公司的评级和目标价。要点  * Doordash DASH.O：加拿大皇家银行将目标价从175美元上调至215美元 * Graftech International Ltd EAF.N：摩根大通将其评级从 \"减持 \"上调至 \"中性\"。* Sagimet Biosciences Inc SGMT.O：奥本海默将其评级从 \"跑赢大盘 \"上调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241206:nL3T3N70G8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FL","BK4503","AEO","IE0002141913.USD","ODFL","DASH","LU2413665964.HKD","SGMT","LU2211815571.USD","LU1778281490.HKD","LU1721428933.USD","GTLB","IE00B64QTZ34.USD","BK4209","NWL","RVMD","SG9999018865.SGD","BK4122","IOT","LU1169589451.USD","UNH","ULTA","HAE","SAIC","VEEV","LU0198837287.USD","IE00B19Z9505.USD","XPO","IE0004445239.USD","EAF","RBRK","LU0353189680.USD","GWRE","BK4123","LU0251132253.USD","GMS","LU2362541273.HKD","SAIA","VSEC","LU0058720904.USD","LU1923621640.USD","BK4548","DOW","IEX","KR","LU2242649171.HKD","SG9999018857.SGD","LU0203345920.USD","LU0950375773.USD"],"gpt_icon":1},{"id":"2489457991","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 快速上涨8.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489457991","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489457991?lang=zh_cn&edition=full","pubTime":"2024-12-05 02:59","pubTimestamp":1733338772,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日02时59分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现波动，股价急速上涨8.79%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体涨幅为0.20%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205025932a1d44021&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205025932a1d44021&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RVMD","RVMDW"],"gpt_icon":0},{"id":"2488687949","title":"Revolution Medicines, Inc.盘中异动 大幅跳水5.06%报49.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488687949","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488687949?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:46","pubTimestamp":1733237213,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时46分，Revolution Medicines, Inc.股票出现波动，股价急速下跌5.06%。Revolution Medicines, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。Revolution Medicines, Inc.公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203224654a2699dff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203224654a2699dff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","BK4139"],"gpt_icon":0},{"id":"2488966885","title":"美国研究综述-花旗集团、Salesforce、Zscaler","url":"https://stock-news.laohu8.com/highlight/detail?id=2488966885","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488966885?lang=zh_cn&edition=full","pubTime":"2024-12-03 15:11","pubTimestamp":1733209873,"startTime":"0","endTime":"0","summary":"美国研究综述-花旗集团、Salesforce、Zscaler路透社12月3日 - 华尔街证券分析师周二调整了对花旗集团、Salesforce 和 Zscaler 等多家美国上市公司的评级和目标价。* Salesforce Inc CRM.N：D.A. Davidson将目标价从250美元上调至300美元 * State Street Corp STT.N：KBW将其评级从 \"市场表现 \"上调至 \"跑赢大盘\"。* Zscaler Inc ZS.O：Piper Sandler将目标价从215美元上调至235美元以下是路透社周二报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nL3S3N40EV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD","HOLX","ZS","ARES","CRM","PTCT","GEV","LGND","STT","C","FDX"],"gpt_icon":1},{"id":"2487496598","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)股价重挫11.20% 市值跌5639.19万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2487496598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487496598?lang=zh_cn&edition=full","pubTime":"2024-11-30 01:50","pubTimestamp":1732902601,"startTime":"0","endTime":"0","summary":"北京时间2024年11月30日01时50分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价大幅下跌11.20%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体涨幅为0.20%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241130015001a25fd0f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241130015001a25fd0f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMDW","RVMD","BK4139"],"gpt_icon":0},{"id":"2486381610","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)股价重挫28.72% 市值跌1.23亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486381610","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486381610?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:38","pubTimestamp":1732545482,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时38分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现波动，股价快速跳水28.72%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体涨幅为1.33%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223802a2548fe3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223802a2548fe3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMDW","RVMD","BK4139"],"gpt_icon":0},{"id":"2485445146","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 大幅拉升5.00%报0.420美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485445146","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485445146?lang=zh_cn&edition=full","pubTime":"2024-11-22 02:11","pubTimestamp":1732212669,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日02时11分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现波动，股价大幅上涨5.00%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体涨幅为0.74%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122021109abd541f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122021109abd541f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","BK4139","RVMDW"],"gpt_icon":0},{"id":"2484920747","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)股价重挫15.09% 市值跌7702.58万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484920747","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484920747?lang=zh_cn&edition=full","pubTime":"2024-11-20 01:00","pubTimestamp":1732035601,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日01时00分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现波动，股价快速下跌15.09%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体跌幅为0.79%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112001000195be4b79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112001000195be4b79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMDW","BK4139","RVMD"],"gpt_icon":0},{"id":"2484410674","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)股价重挫16.36% 市值跌1.07亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484410674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484410674?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:14","pubTimestamp":1731942840,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时14分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价急速下挫16.36%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体跌幅为0.30%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111823140095be490e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111823140095be490e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RVMDW","RVMD"],"gpt_icon":0},{"id":"2483439309","title":"Revolution Medicines, Inc.2024财年第三财季实现净利润-1.56亿美元，同比减少44.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483439309","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483439309?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686420,"startTime":"0","endTime":"0","summary":"11月16日，Revolution Medicines, Inc.公布财报，公告显示公司2024财年第三财季净利润为-1.56亿美元，同比减少44.44%；其中营业收入为0.00美元，每股基本收益为-0.94美元。从资产负债表来看，Revolution Medicines, Inc.总负债1.97亿美元，其中短期债务8.40百万美元，资产负债比为8.95，流动比率为14.23。机构评级：截至2024年11月16日，当前有14家机构对Revolution Medicines, Inc.目标价做出预测，其中目标均价为71.43美元，其中最低目标价为63.00美元，最高目标价为86.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000047abc513a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000047abc513a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD"],"gpt_icon":0},{"id":"2483381214","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 股价大跌7.71%报0.508美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483381214","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483381214?lang=zh_cn&edition=full","pubTime":"2024-11-15 00:50","pubTimestamp":1731603001,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日00时50分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价急速跳水7.71%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体跌幅为0.59%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111500500195be2e0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111500500195be2e0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMDW","RVMD","BK4139"],"gpt_icon":0},{"id":"2483037378","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 下午盘快速下跌8.93%报0.556美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483037378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483037378?lang=zh_cn&edition=full","pubTime":"2024-11-13 02:21","pubTimestamp":1731435664,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日02时21分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现波动，股价急速跳水8.93%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体跌幅为0.85%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113022105971a618d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113022105971a618d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RVMDW","RVMD"],"gpt_icon":0},{"id":"2482873764","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 股价大跌7.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482873764","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482873764?lang=zh_cn&edition=full","pubTime":"2024-11-12 00:30","pubTimestamp":1731342601,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日00时30分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价急速下跌7.89%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体跌幅为0.04%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111200300195be11fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111200300195be11fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","BK4139","RVMDW"],"gpt_icon":0},{"id":"2481104883","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 股价大跌9.23%报0.590美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481104883","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481104883?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:32","pubTimestamp":1731076369,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时32分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价快速下跌9.23%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体涨幅为0.42%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822324995bdef39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822324995bdef39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RVMDW","RVMD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.revmed.com","stockEarnings":[{"period":"1week","weight":-0.0745},{"period":"1month","weight":-0.2078},{"period":"3month","weight":-0.0695},{"period":"6month","weight":0.1246},{"period":"1year","weight":0.6166},{"period":"ytd","weight":0.4983}],"compareEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":-0.0032},{"period":"3month","weight":0.0268},{"period":"6month","weight":0.0767},{"period":"1year","weight":0.2347},{"period":"ytd","weight":0.2335}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Revolution Medicines, Inc.成立于2014年10月，是特拉华州的一家公司。该公司是一家临床阶段的精准肿瘤学公司，专注于开发靶向疗法，以抑制RAS成瘾癌症的前沿靶点。该公司拥有先进的基于结构的药物发现能力，其基础是深厚的化学生物学和癌症药理学知识以及创新的专有技术，能够创造适合非常规结合位点的小分子。该公司对癌症的遗传驱动因素和适应性耐药机制的了解，加上强大的药物发现和药物化学能力，指导建立了一个针对RAS通路和相关通路中的关键信号节点的深层管道。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.002389},{"month":2,"riseRate":0.75,"avgChangeRate":0.00657},{"month":3,"riseRate":0.6,"avgChangeRate":-0.008788},{"month":4,"riseRate":0.6,"avgChangeRate":0.034923},{"month":5,"riseRate":0.4,"avgChangeRate":-0.035334},{"month":6,"riseRate":1,"avgChangeRate":0.06444},{"month":7,"riseRate":0.4,"avgChangeRate":-0.00346},{"month":8,"riseRate":0.6,"avgChangeRate":0.068181},{"month":9,"riseRate":0.4,"avgChangeRate":-0.000203},{"month":10,"riseRate":0.6,"avgChangeRate":-0.028053},{"month":11,"riseRate":0.8,"avgChangeRate":0.161798},{"month":12,"riseRate":0.4,"avgChangeRate":-0.040154}],"exchange":"NASDAQ","name":"Revolution Medicines, Inc.","nameEN":"Revolution Medicines, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Revolution Medicines, Inc.(RVMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Revolution Medicines, Inc.(RVMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Revolution Medicines, Inc.,RVMD,Revolution Medicines, Inc.股票,Revolution Medicines, Inc.股票老虎,Revolution Medicines, Inc.股票老虎国际,Revolution Medicines, Inc.行情,Revolution Medicines, Inc.股票行情,Revolution Medicines, Inc.股价,Revolution Medicines, Inc.股市,Revolution Medicines, Inc.股票价格,Revolution Medicines, Inc.股票交易,Revolution Medicines, Inc.股票购买,Revolution Medicines, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Revolution Medicines, Inc.(RVMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Revolution Medicines, Inc.(RVMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}